Literature DB >> 25232444

Mechanisms for steep pulse irreversible electroporation technology to kill human large cell lung cancer cells L9981.

Zuo-Qing Song1, Xiao-Hong Xu2, Zhen-Hua Pan1, Chen-Guo Yao3, Qing-Hua Zhou1.   

Abstract

To explore the mechanisms for steep pulse irreversible electroporation technology to kill the lung cancer cell L9981. The apoptosis, cells mitochondrial membrane potential, internal PH changes and the intra-cellular calcium ions concentration were detected after steep pulses acted on the human large cell lung cancer cell L9981. Apoptosis test results indicated that cancer cells mainly experienced necrosis and apoptosis. Along with the increase of electric parameters, the proportion of the necrotic cells increased rapidly; the detection of cells mitochondrial membrane potential indicated that membrane potential occurred depolarization. Steep pulse can cause cancer cells to produce death and apoptosis .The PH value indicated that intracellular PH level down jumped. Internal PH became more acidic and led to cell death. The detection of intra-cellular calcium ions concentration showed that the number of free calcium significantly increased, and this change had killing effects on cell death and apoptosis. Steep pulse could induce cell apoptosis.

Entities:  

Keywords:  Steep pulsed; apoptosis; irreversible electrical breakdown; large cell lung cancer; necrosis

Year:  2014        PMID: 25232444      PMCID: PMC4161604     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  13 in total

1.  Apoptosis in C3H-10T1/2 cells: roles of intracellular pH, protein kinase C, and the Na+/H+ antiporter.

Authors:  K M Boyle; J P Irwin; B R Humes; S W Runge
Journal:  J Cell Biochem       Date:  1997-11-01       Impact factor: 4.429

Review 2.  Targeting apoptosis pathways in lung cancer.

Authors:  Milind M Pore; T Jeroen N Hiltermann; Frank A E Kruyt
Journal:  Cancer Lett       Date:  2010-10-25       Impact factor: 8.679

3.  Electronic genetic¿physical and biological aspects of cellular electromanipulation.

Authors:  G A Hofmann; G A Evans
Journal:  IEEE Eng Med Biol Mag       Date:  1986

Review 4.  Current status of clinical high-intensity focused ultrasound.

Authors:  Joo Ha Hwang; Lawrence A Crum
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2009

5.  Radiofrequency ablation of hepatocellular carcinoma: Current status.

Authors:  Yasunori Minami; Masatoshi Kudo
Journal:  World J Radiol       Date:  2010-11-28

6.  Cancer statistics, 2008.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Taylor Murray; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2008-02-20       Impact factor: 508.702

7.  CT-guided radioactive seed implantation for recurrent rectal carcinoma after multiple therapy.

Authors:  Jun Jie Wang; Hui Shu Yuan; Jin Na Li; Yu Liang Jiang; Su Qing Tian; Rui Jie Yang
Journal:  Med Oncol       Date:  2009-05-05       Impact factor: 3.064

Review 8.  TRAIL receptor targeting therapies for non-small cell lung cancer: current status and perspectives.

Authors:  J H Stegehuis; L H A M de Wilt; E G E de Vries; H J Groen; S de Jong; F A E Kruyt
Journal:  Drug Resist Updat       Date:  2009-12-29       Impact factor: 18.500

9.  Relationship between excessive erythrocytosis and acute mountain sickness: a field study.

Authors:  Xiao-Han Ding; Ji-Hang Zhang; Bin Cui; Lan Huang
Journal:  Mil Med Res       Date:  2014-08-21

10.  [Survival analysis of 1,742 patients with stage IV non-small cell lung cancer].

Authors:  Hong Peng; Meili Ma; Baohui Han
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2011-04
View more
  6 in total

1.  CLPTM1L polymorphism and lung cancer risk.

Authors:  Min Tang; Xiaonian Bian; Qiuliang Zhao
Journal:  Int J Clin Exp Med       Date:  2015-03-15

2.  Irreversible electroporation ablation of end-stage metastatic retroperitoneal lesions: Report on three cases and literature review.

Authors:  Tian'An Jiang; Qiyu Zhao; Guo Tian; Xinhua Chen; Liming Wu
Journal:  Exp Ther Med       Date:  2019-07-17       Impact factor: 2.447

3.  Breast tissue ablation with irreversible electroporation in rabbits: A safety and feasibility study.

Authors:  Wenlong Zhang; Wanning Wang; Wei Chai; Xiaomei Luo; Jiannan Li; Jian Shi; Liqi Bi; Lizhi Niu
Journal:  PLoS One       Date:  2017-07-21       Impact factor: 3.240

4.  Novel irreversible electroporation ablation (Nano-knife) versus radiofrequency ablation for the treatment of solid liver tumors: a comparative, randomized, multicenter clinical study.

Authors:  Xiaobo Zhang; Xiao Zhang; Xiaoyi Ding; Zhongmin Wang; Yong Fan; Guang Chen; Xiaokun Hu; Jiasheng Zheng; Zhixiao Xue; Xiaofeng He; Xin Zhang; Yingtian Wei; Zhongliang Zhang; Jing Li; Jie Li; Jie Yang; Xiaodong Xue; Li Ma; Yueyong Xiao
Journal:  Front Oncol       Date:  2022-09-29       Impact factor: 5.738

5.  Rat liver regeneration following ablation with irreversible electroporation.

Authors:  Alexander Golberg; Bote G Bruinsma; Maria Jaramillo; Martin L Yarmush; Basak E Uygun
Journal:  PeerJ       Date:  2016-01-21       Impact factor: 2.984

6.  Efficacy and mechanism of steep pulse irreversible electroporation technology on xenograft model of nude mice: a preclinical study.

Authors:  Zuoqing Song; Xiaohong Xu; Minghui Liu; Jinghao Liu; Jun Chen; Chengxiang Li; Chenguo Yao; Qinghua Zhou
Journal:  World J Surg Oncol       Date:  2018-04-25       Impact factor: 2.754

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.